Clinical Trial Update: LESCOD: "Lewy Body Screening in Cognitive Disorders" [NA]

View source ↗

Summary

The LESCOD study on Lewy body screening in cognitive disorders (NCT02263287) sponsored by Nantes University Hospital has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alzheimer Disease
• Lewy Body Dementia

Snippet

Sponsor: Nantes University Hospital | Conditions: Alzheimer Disease, Lewy Body Disease | NA | Status: TERMINATED